Xianfu Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xianfu Luo has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Jing Ye
Department of Radiology, Northern Jiangsu People's Hospital, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China
8 shared publicationsMartin Prince
7 shared publicationsJun Sun
Department of Radiology, Northern Jiangsu People's Hospital, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China
5 shared publicationsWeiqiang Dou
4 shared publicationsDejuan Shen
Department of Ultrasound, Northern Jiangsu People's Hospital, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China
3 shared publicationsWenjian Wang
Department of Radiology, Northern Jiangsu People's Hospital, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China
3 shared publications
Latest Publications
- 10 January 2026
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 128, 110614
Stratifying non-alcoholic fatty liver disease using diffusion-weighted imaging–based habitat imaging: A rabbit model study
- 10 January 2026
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 128, 110614
Stratifying non-alcoholic fatty liver disease using diffusion-weighted imaging–based habitat imaging: A rabbit model study
- Open Access
- 1 January 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (1) , 88
Amide proton transfer-weighted imaging in predicting aggressiveness of hepatocellular carcinoma: comparison with diffusion-weighted imaging
Amide proton transfer-weighted (APTw) imaging provides molecular-level information for comprehensive tumor characterization, aiding in diagnosis, grading, and treatment response monitoring. The study aimed to investigate the potential of APT imaging in simultaneously predicting three key markers of hepatocellular carcinoma (HCC) aggressiveness—microvascular invasion (MVI), Ki-67 labeling index (LI) and histologic grade—and compare its performance to that of diffusion-weighted imaging (DWI). Fifty-six patients with histologically confirmed HCC underwent abdominal magnetic resonance imaging (MRI) including APTw and DWI. Tumor mean APTw and apparent diffusion coefficient (ADC) values were measured and correlated with Ki-67 LI. The differences of APTw and ADC values between MVI positive (MVI+) and negative (MVI−), high and low Ki-67 LI, and high- and low-grade HCC were analyzed. The diagnostic efficacy of APTw and ADC for predicting HCC aggressiveness was assessed using receiver operating characteristic (ROC) curve analysis. APTw positively correlated with Ki-67 LI (ρ=0.49, P<0.001) and ADC negatively correlated with Ki-67 LI (ρ=−0.27, P=0.04). HCC with MVI+ had higher APTw values than MVI− (1.68%±1.02% vs. 0.21%±1.29%; P<0.001). High Ki-67 LI had higher APTw median values than low Ki-67 LI (1.57% vs. 0.16%; P<0.001). High-grade HCC had higher APTw values than low-grade (1.54%±1.10% vs. 0.02%±1.25%; P<0.001). Diagnostic performance of APTw for predicting MVI+, high Ki-67 LI, and high-grade HCC, was promising with area under the curve values of 0.82 (ADC: 0.65), 0.85 (ADC: 0.76), and 0.82 (ADC: not applicable), respectively. APTw imaging could potentially provide additional value in assessing HCC aggressiveness, complementing the information obtained from DWI.
- 1 January 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (1) , 88
Open AccessAmide proton transfer-weighted imaging in predicting aggressiveness of hepatocellular carcinoma: comparison with diffusion-weighted imaging
Amide proton transfer-weighted (APTw) imaging provides molecular-level information for comprehensive tumor characterization, aiding in diagnosis, grading, and treatment response monitoring. The study aimed to investigate the potential of APT imaging in simultaneously predicting three key markers of hepatocellular carcinoma (HCC) aggressiveness—microvascular invasion (MVI), Ki-67 labeling index (LI) and histologic grade—and compare its performance to that of diffusion-weighted imaging (DWI). Fifty-six patients with histologically confirmed HCC underwent abdominal magnetic resonance imaging (MRI) including APTw and DWI. Tumor mean APTw and apparent diffusion coefficient (ADC) values were measured and correlated with Ki-67 LI. The differences of APTw and ADC values between MVI positive (MVI+) and negative (MVI−), high and low Ki-67 LI, and high- and low-grade HCC were analyzed. The diagnostic efficacy of APTw and ADC for predicting HCC aggressiveness was assessed using receiver operating characteristic (ROC) curve analysis. APTw positively correlated with Ki-67 LI (ρ=0.49, P<0.001) and ADC negatively correlated with Ki-67 LI (ρ=−0.27, P=0.04). HCC with MVI+ had higher APTw values than MVI− (1.68%±1.02% vs. 0.21%±1.29%; P<0.001). High Ki-67 LI had higher APTw median values than low Ki-67 LI (1.57% vs. 0.16%; P<0.001). High-grade HCC had higher APTw values than low-grade (1.54%±1.10% vs. 0.02%±1.25%; P<0.001). Diagnostic performance of APTw for predicting MVI+, high Ki-67 LI, and high-grade HCC, was promising with area under the curve values of 0.82 (ADC: 0.65), 0.85 (ADC: 0.76), and 0.82 (ADC: not applicable), respectively. APTw imaging could potentially provide additional value in assessing HCC aggressiveness, complementing the information obtained from DWI.
- 9 August 2025
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 123, 110491
Amide proton transfer-weighted MRI distinguishes hepatocellular carcinoma from mass-forming intrahepatic cholangiocarcinoma
- 9 August 2025
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 123, 110491
Amide proton transfer-weighted MRI distinguishes hepatocellular carcinoma from mass-forming intrahepatic cholangiocarcinoma
- 17 July 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (2) , 758-767
Common bile duct dilatation on MRI in autosomal dominant polycystic kidney disease
Purpose Polycystic liver disease is the most prevalent extrarenal manifestation of autosomal dominant polycystic kidney disease (ADPKD). Non-obstructive asymptomatic common bile duct (CBD) dilatation has been observed anecdotally on CT scans, but CT is not optimal for biliary visualization. Here, we measured CBD diameter on T2-weighted MRI in ADPKD subjects to determine if CBD dilatation is associated with ADPKD. Methods CBD diameter was measured retrospectively on ADPKD subjects (n = 254) and on age- and sex-matched controls without ADPKD (n = 254) who underwent abdominal MRI. CBD diameter in these groups was compared and correlated with clinical, laboratory and magnetic resonance imaging (MRI) features, including organ volumes and cyst burden. Results CBD median diameter [interquartile range, IQR, 25%, 75%] was 22% larger in ADPKD compared to controls (5.6 [4.7, 6.9] mm vs. 4.6 [3.9, 5.4] mm, p < 0.001). CBD diameter measurements had excellent inter-observer agreement (Intraclass correlation coefficient = 0.92). Thirteen (5.1%) ADPKD subjects had a CBD diameter ≥ 10 mm compared to 1 (0.4%) control subject (p < 0.001). Multivariable analysis found the presence of PKD1 or PKD2 mutation (beta = 1.5, P < 0.001) and age (beta = 0.04, p < 0.001) to be associated with increased CBD diameter and serum albumin associated with decreased CBD diameter (beta=-0.39, p < 0.001). Conclusion ADPKD subjects had 22% larger CBD diameters than in non-ADPKD controls and were more likely to have CBD dilatation ≥ 10 mm without CBD obstruction. Awareness of this association of non-obstructive CBD dilatation with ADPKD may limit unnecessary diagnostic testing.
- 17 July 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (2) , 758-767
Common bile duct dilatation on MRI in autosomal dominant polycystic kidney disease
Purpose Polycystic liver disease is the most prevalent extrarenal manifestation of autosomal dominant polycystic kidney disease (ADPKD). Non-obstructive asymptomatic common bile duct (CBD) dilatation has been observed anecdotally on CT scans, but CT is not optimal for biliary visualization. Here, we measured CBD diameter on T2-weighted MRI in ADPKD subjects to determine if CBD dilatation is associated with ADPKD. Methods CBD diameter was measured retrospectively on ADPKD subjects (n = 254) and on age- and sex-matched controls without ADPKD (n = 254) who underwent abdominal MRI. CBD diameter in these groups was compared and correlated with clinical, laboratory and magnetic resonance imaging (MRI) features, including organ volumes and cyst burden. Results CBD median diameter [interquartile range, IQR, 25%, 75%] was 22% larger in ADPKD compared to controls (5.6 [4.7, 6.9] mm vs. 4.6 [3.9, 5.4] mm, p < 0.001). CBD diameter measurements had excellent inter-observer agreement (Intraclass correlation coefficient = 0.92). Thirteen (5.1%) ADPKD subjects had a CBD diameter ≥ 10 mm compared to 1 (0.4%) control subject (p < 0.001). Multivariable analysis found the presence of PKD1 or PKD2 mutation (beta = 1.5, P < 0.001) and age (beta = 0.04, p < 0.001) to be associated with increased CBD diameter and serum albumin associated with decreased CBD diameter (beta=-0.39, p < 0.001). Conclusion ADPKD subjects had 22% larger CBD diameters than in non-ADPKD controls and were more likely to have CBD dilatation ≥ 10 mm without CBD obstruction. Awareness of this association of non-obstructive CBD dilatation with ADPKD may limit unnecessary diagnostic testing.
- 24 December 2024
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 98 (1167) , 458-468
CT-based liver peritumoural radiomics features predict hepatic metastases sources as gastrointestinal or non-gastrointestinal
To investigate the feasibility of radiomics models for predicting the source of hepatic metastases from gastrointestinal (GI) vs. non-gastrointestinal (non-GI) primary tumors on contrast enhanced CT(CECT). 347 patients with liver metastases (180 from GI and 167 from non-GI) and abdominal CECT including arterial, portal venous, and delayed phases were divided into training (221) and validation (96) sets at a ratio of 7:3 and an independent testing set (30). Radiomics features were extracted from volumes of interest (VOIs) including tumoral (Vtc) and peritumoral (Vpt) regions on CECT. Optimal radiomics features were used in logistic regression models using receiver operating curve (ROC) analysis to evaluate the diagnostic efficiency. The best single-phase model was a venous phase peritumoral VOI with 11 features. Area under the curve (AUC), sensitivity and specificity were 0.817, 0.740 and 0.761, respectively in the validation set. While the best arterial phase tumoral VOI gave an AUC of 0.677 in the validation set. For the combined models, peritumoral VOI in arterial and venous phases (15 features) achieved the best prediction performance with an AUC of 0.926 in the validation set and 0.884 in the testing set. Liver peritumoral radiomics features extracted from CECT were able to identify the source of hepatic metastases as GI versus non-GI. Peritumoral radiomics features showed a correlation with source of liver metastases. The radiomics features from liver peritumoral arterial and venous phases CT were promising in differentiating the source of hepatic metastases from GI vs. non-GI primary tumors.
- 24 December 2024
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 98 (1167) , 458-468
CT-based liver peritumoural radiomics features predict hepatic metastases sources as gastrointestinal or non-gastrointestinal
To investigate the feasibility of radiomics models for predicting the source of hepatic metastases from gastrointestinal (GI) vs. non-gastrointestinal (non-GI) primary tumors on contrast enhanced CT(CECT). 347 patients with liver metastases (180 from GI and 167 from non-GI) and abdominal CECT including arterial, portal venous, and delayed phases were divided into training (221) and validation (96) sets at a ratio of 7:3 and an independent testing set (30). Radiomics features were extracted from volumes of interest (VOIs) including tumoral (Vtc) and peritumoral (Vpt) regions on CECT. Optimal radiomics features were used in logistic regression models using receiver operating curve (ROC) analysis to evaluate the diagnostic efficiency. The best single-phase model was a venous phase peritumoral VOI with 11 features. Area under the curve (AUC), sensitivity and specificity were 0.817, 0.740 and 0.761, respectively in the validation set. While the best arterial phase tumoral VOI gave an AUC of 0.677 in the validation set. For the combined models, peritumoral VOI in arterial and venous phases (15 features) achieved the best prediction performance with an AUC of 0.926 in the validation set and 0.884 in the testing set. Liver peritumoral radiomics features extracted from CECT were able to identify the source of hepatic metastases as GI versus non-GI. Peritumoral radiomics features showed a correlation with source of liver metastases. The radiomics features from liver peritumoral arterial and venous phases CT were promising in differentiating the source of hepatic metastases from GI vs. non-GI primary tumors.
- 31 January 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (4) , 1051-1062
Gd-EOB-DTPA enhanced MRI based radiomics combined with clinical variables in stratifying hepatic functional reserve in HBV infected patients
Purposes To evaluate radiomics from Gd-EOB-DTPA enhanced MR combined with clinical variables for stratifying hepatic functional reserve in hepatitis B virus (HBV) patients. Methods Our study included 279 chronic HBV patients divided 8:2 for training and test cohorts. Radiomics features were extracted from the hepatobiliary phase (HBP) MR images. Radiomics features were selected to construct a Rad-score which was combined with clinical parameters in two models differentiating hepatitis vs. Child–Pugh A and Child–Pugh A vs. B/C. Performances of these stratifying models were compared using area under curve (AUC). Results Rad-score alone discriminated hepatitis vs. Child–Pugh A with AUC = 0.890, 0.914 and Child–Pugh A vs. B/C with AUC = 0.862, 0.865 for the training and test cohorts, respectively. Model 1 [Rad-score + clinical parameters for hepatitis vs. Child–Pugh A] showed AUC = 0.978 for the test cohort, which was higher than ALBI [albumin-bilirubin] and MELD [model for end-stage liver disease], with AUCs of 0.716, 0.799, respectively (p < 0.001, < 0.001). Model 2 [Rad-score + clinical parameters for Child–Pugh A vs. B/C] showed AUC of 0.890 in the test cohort, which was similar to ALBI (AUC = 0.908, p = 0.760), and higher than MELD (AUC = 0.709, p = 0.018). Conclusion Rad-score combined with clinical variables stratifies hepatic functional reserve in HBV patients. Graphical abstract
- 31 January 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (4) , 1051-1062
Gd-EOB-DTPA enhanced MRI based radiomics combined with clinical variables in stratifying hepatic functional reserve in HBV infected patients
Purposes To evaluate radiomics from Gd-EOB-DTPA enhanced MR combined with clinical variables for stratifying hepatic functional reserve in hepatitis B virus (HBV) patients. Methods Our study included 279 chronic HBV patients divided 8:2 for training and test cohorts. Radiomics features were extracted from the hepatobiliary phase (HBP) MR images. Radiomics features were selected to construct a Rad-score which was combined with clinical parameters in two models differentiating hepatitis vs. Child–Pugh A and Child–Pugh A vs. B/C. Performances of these stratifying models were compared using area under curve (AUC). Results Rad-score alone discriminated hepatitis vs. Child–Pugh A with AUC = 0.890, 0.914 and Child–Pugh A vs. B/C with AUC = 0.862, 0.865 for the training and test cohorts, respectively. Model 1 [Rad-score + clinical parameters for hepatitis vs. Child–Pugh A] showed AUC = 0.978 for the test cohort, which was higher than ALBI [albumin-bilirubin] and MELD [model for end-stage liver disease], with AUCs of 0.716, 0.799, respectively (p < 0.001, < 0.001). Model 2 [Rad-score + clinical parameters for Child–Pugh A vs. B/C] showed AUC of 0.890 in the test cohort, which was similar to ALBI (AUC = 0.908, p = 0.760), and higher than MELD (AUC = 0.709, p = 0.018). Conclusion Rad-score combined with clinical variables stratifies hepatic functional reserve in HBV patients. Graphical abstract
- Open Access
- 3 January 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (1) , 386
Pleural Effusions on MRI in Autosomal Dominant Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease (ADPKD) has cystic fluid accumulations in the kidneys, liver, pancreas, arachnoid spaces as well as non-cystic fluid accumulations including pericardial effusions, dural ectasia and free fluid in the male pelvis. Here, we investigate the possible association of ADPKD with pleural effusion. ADPKD subjects (n = 268) and age-gender matched controls without ADPKD (n = 268) undergoing body magnetic resonance imaging from mid-thorax down into the pelvis were independently evaluated for pleural effusion by 3 blinded expert observers. Subjects with conditions associated with pleural effusion were excluded from both populations. Clinical and laboratory data as well as kidney, liver and spleen volume, pleural fluid volume, free pelvic fluid and polycystic kidney disease genotype were evaluated. Pleural effusions were observed in 56 of 268 (21%) ADPKD subjects compared with 21 of 268 (8%) in controls (p < 0.0001). In a subpopulation controlling for renal function by matching estimated glomerular filtration rate (eGFR), 28 of 110 (25%) ADPKD subjects had pleural effusions compared to 5 of 110 (5%) controls (p < 0.001). Pleural effusions in ADPKD subjects were more prevalent in females (37/141; 26%) than males (19/127,15%; p = 0.02) and in males were weakly correlated with the presence of free pelvic fluid (r = 0.24, p = 0.02). ADPKD subjects with pleural effusions were younger (48 ± 14 years old vs. 43 ± 14 years old) and weighed less (77 vs. 70 kg; p ≤ 0.02) than those without pleural effusions. For ADPKD subjects with pleural effusions, the mean volume of fluid layering dependently in the posterior–inferior thorax was 19 mL and was not considered to be clinically significant. Pleural effusion is associated with ADPKD, but its role in the pathogenesis of ADPKD requires further evaluation.
- 3 January 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (1) , 386
Open AccessPleural Effusions on MRI in Autosomal Dominant Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease (ADPKD) has cystic fluid accumulations in the kidneys, liver, pancreas, arachnoid spaces as well as non-cystic fluid accumulations including pericardial effusions, dural ectasia and free fluid in the male pelvis. Here, we investigate the possible association of ADPKD with pleural effusion. ADPKD subjects (n = 268) and age-gender matched controls without ADPKD (n = 268) undergoing body magnetic resonance imaging from mid-thorax down into the pelvis were independently evaluated for pleural effusion by 3 blinded expert observers. Subjects with conditions associated with pleural effusion were excluded from both populations. Clinical and laboratory data as well as kidney, liver and spleen volume, pleural fluid volume, free pelvic fluid and polycystic kidney disease genotype were evaluated. Pleural effusions were observed in 56 of 268 (21%) ADPKD subjects compared with 21 of 268 (8%) in controls (p < 0.0001). In a subpopulation controlling for renal function by matching estimated glomerular filtration rate (eGFR), 28 of 110 (25%) ADPKD subjects had pleural effusions compared to 5 of 110 (5%) controls (p < 0.001). Pleural effusions in ADPKD subjects were more prevalent in females (37/141; 26%) than males (19/127,15%; p = 0.02) and in males were weakly correlated with the presence of free pelvic fluid (r = 0.24, p = 0.02). ADPKD subjects with pleural effusions were younger (48 ± 14 years old vs. 43 ± 14 years old) and weighed less (77 vs. 70 kg; p ≤ 0.02) than those without pleural effusions. For ADPKD subjects with pleural effusions, the mean volume of fluid layering dependently in the posterior–inferior thorax was 19 mL and was not considered to be clinically significant. Pleural effusion is associated with ADPKD, but its role in the pathogenesis of ADPKD requires further evaluation.
- 18 September 2021
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 16 (2) , 728-737
The altered functional modular organization in systemic lupus erythematosus: an independent component analysis study
The aim of this study was to investigate the abnormities in functional connectivity (FC) within each modular network and between modular networks in patients with systemic lupus erythematosus (SLE). Twelve meaningful modular networks were identified via independent component analysis from 41 patients and 40 volunteers. Parametric tests were used to compare the intra- and intermodular FC between the groups. Partial correlation analysis was used to seek the relationships between abnormal FCs and the clinical data. Compared to the controls, SLE patients showed decreased intramodular FC in the anterior default mode network (aDMN), posterior default mode network (pDMN), ventral attention network (VAN), and sensorimotor network (SMN) and increased intramodular FC in the medial visual network (mVN) and left frontoparietal network. In addition, SLE patients showed decreased intermodular FC between the SMN and the lateral visual network (lVN), between the SMN and the VAN, and between the pDMN and the lVN and exhibited increased intermodular FC between the SMN and the salience network (SAN), between the pDMN and the SAN, and between the aDMN and the VAN. Moreover, we found several correlations among the abnormal FCs and the Mini-Mental State Examination in SLE patients. Mild cognitive impairment is compensated by the hyperconnectivity between the aDMN and the VAN, while severe cognitive impairment tends to be compensated by the hyperconnectivity between the SMN and the SAN. The FC value between the SMN and the SAN and between the aDMN and the VAN may serve as neuroimaging markers for monitoring cognitive progression in SLE patients.
- 18 September 2021
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 16 (2) , 728-737
The altered functional modular organization in systemic lupus erythematosus: an independent component analysis study
The aim of this study was to investigate the abnormities in functional connectivity (FC) within each modular network and between modular networks in patients with systemic lupus erythematosus (SLE). Twelve meaningful modular networks were identified via independent component analysis from 41 patients and 40 volunteers. Parametric tests were used to compare the intra- and intermodular FC between the groups. Partial correlation analysis was used to seek the relationships between abnormal FCs and the clinical data. Compared to the controls, SLE patients showed decreased intramodular FC in the anterior default mode network (aDMN), posterior default mode network (pDMN), ventral attention network (VAN), and sensorimotor network (SMN) and increased intramodular FC in the medial visual network (mVN) and left frontoparietal network. In addition, SLE patients showed decreased intermodular FC between the SMN and the lateral visual network (lVN), between the SMN and the VAN, and between the pDMN and the lVN and exhibited increased intermodular FC between the SMN and the salience network (SAN), between the pDMN and the SAN, and between the aDMN and the VAN. Moreover, we found several correlations among the abnormal FCs and the Mini-Mental State Examination in SLE patients. Mild cognitive impairment is compensated by the hyperconnectivity between the aDMN and the VAN, while severe cognitive impairment tends to be compensated by the hyperconnectivity between the SMN and the SAN. The FC value between the SMN and the SAN and between the aDMN and the VAN may serve as neuroimaging markers for monitoring cognitive progression in SLE patients.
- Open Access
- 1 May 2021
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 11 (5) , 2001-2012
Simultaneous hepatic iron and fat quantification with dual-energy CT in a rabbit model of coexisting iron and fat
Background: Liver iron and fat are often co-deposited, synergistically aggravating the progression of chronic liver disease. Accurate determination of liver iron and fat content is helpful for patient management. To assess the accuracy of hepatic iron/fat decomposition using dual-energy computed tomography (DECT) for simultaneously quantifying hepatic iron and fat when both are present. Methods: Sixty-eight New Zealand rabbits on a high-fat/cholesterol diet plus iron injections were used to establish a model of coexisting hepatic iron/fat. Abdominal imaging was performed using dual-source DECT. The iron and fat fractions (Iron-CT and Fat-CT, respectively) were calculated using a 3-material decomposition algorithm. The spectroscopic liver iron concentration (LIC) grading (normal, mild, moderate, severe, and massive iron overload) and the histopathological fat fraction (Fat-ref) grading (normal, mild, moderate, severe steatosis) were used as references. Correlations between the DECT parameters and the references were analyzed. Hepatic iron/fat quantification equations were established and validated. Analysis of covariance was used to assess the influence of fat on iron measurements and vice versa. Results: Iron-CT highly correlated with LIC (r=0.94, PCT highly correlated with Fat-ref (r=0.88, P15.0 mg Fe/g (270 µmol/g)] the regression began to deviate, causing fat underestimation (F=5.50, P=0.04). Conclusions: Our DECT-based iron/fat decomposition algorithm accurately measured hepatic iron and fat when both were present in a rabbit model. Hepatic fat may be underestimated when there is massive iron overload.
- 1 May 2021
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 11 (5) , 2001-2012
Open AccessSimultaneous hepatic iron and fat quantification with dual-energy CT in a rabbit model of coexisting iron and fat
Background: Liver iron and fat are often co-deposited, synergistically aggravating the progression of chronic liver disease. Accurate determination of liver iron and fat content is helpful for patient management. To assess the accuracy of hepatic iron/fat decomposition using dual-energy computed tomography (DECT) for simultaneously quantifying hepatic iron and fat when both are present. Methods: Sixty-eight New Zealand rabbits on a high-fat/cholesterol diet plus iron injections were used to establish a model of coexisting hepatic iron/fat. Abdominal imaging was performed using dual-source DECT. The iron and fat fractions (Iron-CT and Fat-CT, respectively) were calculated using a 3-material decomposition algorithm. The spectroscopic liver iron concentration (LIC) grading (normal, mild, moderate, severe, and massive iron overload) and the histopathological fat fraction (Fat-ref) grading (normal, mild, moderate, severe steatosis) were used as references. Correlations between the DECT parameters and the references were analyzed. Hepatic iron/fat quantification equations were established and validated. Analysis of covariance was used to assess the influence of fat on iron measurements and vice versa. Results: Iron-CT highly correlated with LIC (r=0.94, PCT highly correlated with Fat-ref (r=0.88, P15.0 mg Fe/g (270 µmol/g)] the regression began to deviate, causing fat underestimation (F=5.50, P=0.04). Conclusions: Our DECT-based iron/fat decomposition algorithm accurately measured hepatic iron and fat when both were present in a rabbit model. Hepatic fat may be underestimated when there is massive iron overload.
- 26 June 2020
- Published by Springer Nature in European Radiology
- Vol. 30 (11) , 6022-6032
Comparing mono-exponential, bi-exponential, and stretched-exponential diffusion-weighted MR imaging for stratifying non-alcoholic fatty liver disease in a rabbit model
Objectives To compare diffusion parameters obtained from mono-exponential, bi-exponential, and stretched-exponential diffusion-weighted imaging (DWI) in stratifying non-alcoholic fatty liver disease (NAFLD). Methods Thirty-two New Zealand rabbits were fed a high-fat/cholesterol or standard diet to obtain different stages of NAFLD before 12 b-values (0–800 s/mm2) DWI. The apparent diffusion coefficient (ADC) from the mono-exponential model; pure water diffusion (D), pseudo-diffusion (D*), and perfusion fraction (f) from bi-exponential DWI; and distributed diffusion coefficient (DDC) and water molecular diffusion heterogeneity index (α) from stretched-exponential DWI were calculated for hepatic parenchyma. The goodness of fit of the three models was compared. NAFLD severity was pathologically graded as normal, simple steatosis, borderline, and non-alcoholic steatohepatitis (NASH). Spearman rank correlation analysis and receiver operating characteristic curves were used to assess NAFLD severity. Results Upon comparison, the goodness of fit chi-square from stretched-exponential fitting (0.077 ± 0.012) was significantly lower than that for the bi-exponential (0.110 ± 0.090) and mono-exponential (0.181 ± 0.131) models (p < 0.05). Seven normal, 8 simple steatosis, 6 borderline, and 11 NASH livers were pathologically confirmed from 32 rabbits. Both α and D increased with increasing NAFLD severity (r = 0.811 and 0.373, respectively; p < 0.05). ADC, f, and DDC decreased as NAFLD severity increased (r = − 0.529, − 0.717, and − 0.541, respectively; p < 0.05). Both α (area under the curve [AUC] = 0.952) and f (AUC = 0.931) had significantly greater AUCs than ADC (AUC = 0.727) in the differentiation of NASH from borderline or less severe groups (p < 0.05). Conclusions Stretched-exponential DWI with higher fitting efficiency performed, as well as bi-exponential DWI, better than mono-exponential DWI in the stratification of NAFLD severity. Key Points • Stretched-exponential diffusion model fitting was more reliable than the bi-exponential and mono-exponential diffusion models (p = 0.039 and p < 0.001, respectively). • As NAFLD severity increased, the diffusion heterogeneity index (α) increased, while the perfusion fraction (f) decreased (r = 0.811, − 0.717, p < 0.05). • Both α and f showed superior NASH diagnostic performance (AUC = 0.952, 0.931) compared with ADC (AUC = 0.727, p < 0.05).
- 26 June 2020
- Published by Springer Nature in European Radiology
- Vol. 30 (11) , 6022-6032
Comparing mono-exponential, bi-exponential, and stretched-exponential diffusion-weighted MR imaging for stratifying non-alcoholic fatty liver disease in a rabbit model
Objectives To compare diffusion parameters obtained from mono-exponential, bi-exponential, and stretched-exponential diffusion-weighted imaging (DWI) in stratifying non-alcoholic fatty liver disease (NAFLD). Methods Thirty-two New Zealand rabbits were fed a high-fat/cholesterol or standard diet to obtain different stages of NAFLD before 12 b-values (0–800 s/mm2) DWI. The apparent diffusion coefficient (ADC) from the mono-exponential model; pure water diffusion (D), pseudo-diffusion (D*), and perfusion fraction (f) from bi-exponential DWI; and distributed diffusion coefficient (DDC) and water molecular diffusion heterogeneity index (α) from stretched-exponential DWI were calculated for hepatic parenchyma. The goodness of fit of the three models was compared. NAFLD severity was pathologically graded as normal, simple steatosis, borderline, and non-alcoholic steatohepatitis (NASH). Spearman rank correlation analysis and receiver operating characteristic curves were used to assess NAFLD severity. Results Upon comparison, the goodness of fit chi-square from stretched-exponential fitting (0.077 ± 0.012) was significantly lower than that for the bi-exponential (0.110 ± 0.090) and mono-exponential (0.181 ± 0.131) models (p < 0.05). Seven normal, 8 simple steatosis, 6 borderline, and 11 NASH livers were pathologically confirmed from 32 rabbits. Both α and D increased with increasing NAFLD severity (r = 0.811 and 0.373, respectively; p < 0.05). ADC, f, and DDC decreased as NAFLD severity increased (r = − 0.529, − 0.717, and − 0.541, respectively; p < 0.05). Both α (area under the curve [AUC] = 0.952) and f (AUC = 0.931) had significantly greater AUCs than ADC (AUC = 0.727) in the differentiation of NASH from borderline or less severe groups (p < 0.05). Conclusions Stretched-exponential DWI with higher fitting efficiency performed, as well as bi-exponential DWI, better than mono-exponential DWI in the stratification of NAFLD severity. Key Points • Stretched-exponential diffusion model fitting was more reliable than the bi-exponential and mono-exponential diffusion models (p = 0.039 and p < 0.001, respectively). • As NAFLD severity increased, the diffusion heterogeneity index (α) increased, while the perfusion fraction (f) decreased (r = 0.811, − 0.717, p < 0.05). • Both α and f showed superior NASH diagnostic performance (AUC = 0.952, 0.931) compared with ADC (AUC = 0.727, p < 0.05).